- Previous Close
0.0000 - Open
0.2000 - Bid 0.0210 x --
- Ask 0.2000 x --
- Day's Range
0.2000 - 0.2000 - 52 Week Range
0.1890 - 0.2000 - Volume
2,500 - Avg. Volume
557 - Market Cap (intraday)
14.223M - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date May 15, 2025 - May 19, 2025
- Forward Dividend & Yield 0.01 (3.55%)
- Ex-Dividend Date Dec 16, 2024
- 1y Target Est
--
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. The company also provides ancillary services. TNexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
www.nexgenrx.comRecent News: NEGXF
View More
Performance Overview: NEGXF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NEGXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NEGXF
View MoreValuation Measures
Market Cap
12.62M
Enterprise Value
12.82M
Trailing P/E
277.25
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.22
Price/Book (mrq)
3.06
Enterprise Value/Revenue
1.12
Enterprise Value/EBITDA
11.18
Financial Highlights
Profitability and Income Statement
Profit Margin
1.58%
Return on Assets (ttm)
0.98%
Return on Equity (ttm)
3.06%
Revenue (ttm)
16.11M
Net Income Avi to Common (ttm)
254.52k
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.84M
Total Debt/Equity (mrq)
5.78%
Levered Free Cash Flow (ttm)
736.59k